Spark Therapeutics Aktie
-
Deine Einschätzung
Was spricht für und gegen Spark Therapeutics in den nächsten Jahren?
Pro
Kontra
Rendite von Spark Therapeutics im Vergleich
| Wertpapier | Ver.(%) | 1W | 1M | 1J | YTD | 3J | 5J |
|---|---|---|---|---|---|---|---|
| Spark Therapeutics | - | - | - | - | - | - | - |
| Ligand Pharmaceuticals | 1,02 % | 4,21 % | 11,86 % | 107,33 % | 19,28 % | 182,86 % | 63,70 % |
| United Therapeutics | -1,16 % | -3,22 % | 3,31 % | 88,66 % | 13,29 % | 134,89 % | 176,63 % |
| Ionis Pharmaceuticals Inc. | -1,86 % | -2,80 % | -0,51 % | 139,16 % | -7,98 % | 91,20 % | 77,12 % |
Kommentare
News
The Quiet Retail Compounder Investors Keep Buying on Every Dip
Casey’s General Stores (NASDAQ: CASY) is a long-term retail holding that has tended to reward a buy-the-dip strategy. This company is as quality as they come, internally funding growth
Unity Software Is Falling—So Why Are Pros Getting More Bullish?
Unity Software (NYSE: U) experienced a jarring sell-off in mid-January 2026. The stock tumbled nearly 7% to close around $40.96, capping off its difficult start to 2026. For an investor looking
Why FuelCell Energy Stock Is Soaring After a Government Deal
After months of downward pressure, FuelCell Energy (NASDAQ: FCEL) has roared back to life.
Its stock price has risen more than 20% over three trading sessions ending in early December



